ArticleFrontiers in neuroscience2025

An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease.

Christopher L Reading et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.